CompletedPhase 1ACTRN12617001519347

Effect of atropine eye drops on thinning of the ocular choroid induced by retinal image defocus in adults with myopia (near-sightedness)

Effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus in adults with myopia


Sponsor

The University of Auckland

Enrollment

12 participants

Start Date

Nov 24, 2014

Study Type

Interventional

Conditions

Summary

Myopia of any degree increases the risk of developing sight-threatening conditions such as glaucoma, retinal detachment and myopic maculopathy with risk increasing dramatically with progression to high myopia. Atropine eye drops are currently the most effective treatment for managing myopia progression, but the mode of action is unclear. The aim of this study was to investigate the effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus, using automated measures of choroidal thickness obtained with swept-source optical coherence tomography (SS-OCT). A secondary aim was to record the short-term effect of atropine on the resting thickness of the choroid.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 25 Yearss

Exclusion Criteria1

  • Individuals with amblyopia, ocular pathology or other ocular anomalies (e.g. surgery, trauma) that might have influenced the measurements were excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

One drop 0.5% atropine eye drop to non-dominant eye on one occasion, instilled by the research optometrist

One drop 0.5% atropine eye drop to non-dominant eye on one occasion, instilled by the research optometrist


Locations(1)

Auckland, New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12617001519347


Related Trials